Innovacell Biotechnologie AG is an innovative biotechnology company that develops personalized cell therapies for treatment of incontinence. Innovacell is running multinational clinical trials for its two ‘tissue-engineered’ products in development, ICES13 and ICEF15. Using Innovacell’s innovative ‘ultrasound-guided’ injector, patients benefit from a minimally invasive surgery. More than 500 patients have been treated since 2002.
General News: 2012-11-16Staff Change at the Executive Board Please be informed that Mr. Hepberger has resigned from the Executive Board with effect from October 31st 2012 for personal reasons. Innovacell regrets Mr. Hepberger´s resignation. read more »